Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Traditional Chinese Medicine ; (12): 1954-1960, 2023.
Artigo em Chinês | WPRIM | ID: wpr-988798

RESUMO

With reference to the comprehensive evaluation system for the clinical effectiveness of Chinese patent medicine, this paper summarized the current status and problems of the comprehensive evaluation of the clinical effectiveness of traditional Chinese medicine (TCM) in the treatment of malignant tumors from seven aspects, including safety, effectiveness, cost-effectiveness, innovation, suitability, accessibility, and TCM features. On this basis, the characteristics of TCM and the disciplinary characteristics of oncology are considered, and multiple sources of evidence, focus on dominant groups of people, consideration of economic toxicity, paying attention to post-marketing research, targeting at patients' willingness of medication, anchoring the supply of TCM services, and introducing symptoms threshold events are further emphasized. Moreover, methods such as nested case-control studies, enrichment designs, real-world research, and intelligent TCM diagnosis and treatment platforms are used to obtain high-level clinical evidence, ultimately building a scientific, homogeneous, and standardized comprehensive evaluation system for the clinical effectiveness of TCM in the treatment of malignant tumors.

2.
China Journal of Chinese Materia Medica ; (24): 1980-1987, 2021.
Artigo em Chinês | WPRIM | ID: wpr-879118

RESUMO

Traditional Chinese medicine(TCM) is an important feature of cancer treatment in China. The methods to tap the advantages of TCM, reasonably evaluate and accurately apply Chinese patent medicines have become current research hotspots and difficulties. TCM takes syndrome differentiation and treatment as the core, with the characteristics of overall regulation and multi-targets efficacy. Therefore, the post-marketing survival benefit evaluation of Chinese patent medicines for cancer is different from that in modern medicine. The primary treatment goals in cancer patients include to improve the disease control rate and prolong their survival time. At present, Chinese patent medicines for cancer patients are lacking indepth studies on survival benefit at the post-marketing stage. In addition, the characteristics of individualized treatment with TCM have also increased the complexity of clinical research on TCM. Therefore, it is of certain practical significance and necessity to evaluate the survival benefit of Chinese patent medicines for cancer after marketing. Based on this, in this paper, we first summarized the technical methodological means of survival benefit evaluation at this stage, and then explored the post-marketing survival benefit evaluation of Chinese patent medicines for cancer from three aspects: the evaluation of cancer treatment effect based on survival time and quality of life, treatment-related toxicity and the auxiliary effect of TCM, and the improvement effect for tumor-related symptoms. Based on the practices of early clinical researches, and according to the insufficient efficacy evaluation of current clinical research on Chinese patent medicines, this paper proposed to improve the evaluation system for clinical researches on Chinese patent medicines, establish the evaluation method with TCM characteristics, clarify the dominant population, lay a theoretical foundation for the evaluation of post-marketing survival benefits of Chinese patent medicines for cancer in the future, and promote the modernization process of TCM.


Assuntos
Humanos , China , Medicamentos de Ervas Chinesas/uso terapêutico , Marketing , Medicina Tradicional Chinesa , Neoplasias/tratamento farmacológico , Medicamentos sem Prescrição/uso terapêutico , Qualidade de Vida
3.
Microbiology ; (12)2008.
Artigo em Chinês | WPRIM | ID: wpr-686105

RESUMO

Field studies were conducted for a season to determine potential for alterations in the rhizosphere fungi quantity dynamics and dominant populations of 4 wild sugarcane clones(S.spontaneum L.) with different UV-B sensitivity under an enhanced ultraviolet-B(UV-B,280 nm~310 nm) radiation.The quantity of rhizosphere fungi was most in tillering stage,second in seedling stage and lest in elongating stage and maturing stage,the sequence wasn’t alternated by UV-B radiation.The rhizosphere fungi quantity of tolerant clone was obviously increased and greater than the sensitive clone under the enhanced UV-B radiation,however,the number of dominant populations decreased and Penicillium was the dominant population during the periods of 4 wild sugarcane clones.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA